| P50 | author | Josep Guarro Artigas | Q36591058 |
| P2093 | author name string | Enrique Calvo | |
| | Emilio Mayayo | |
| | F Javier Pastor | |
| | Valentina Salas | |
| P2860 | cites work | Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America | Q28263689 |
| | In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates | Q28345261 |
| | Anidulafungin and voriconazole in invasive fungal disease: pharmacological data and their use in combination | Q33490772 |
| | Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus | Q33857685 |
| | Pharmacokinetics/pharmacodynamics of echinocandins | Q34551922 |
| | In vitro evaluation of double and triple combinations of antifungal drugs against Aspergillus fumigatus and Aspergillus terreus | Q36492208 |
| | The safety of anidulafungin | Q36624970 |
| | Fungal infections in hematopoietic stem cell transplant recipients | Q37139544 |
| | Combination therapy of advanced invasive pulmonary aspergillosis in transiently neutropenic rats using human pharmacokinetic equivalent doses of voriconazole and anidulafungin | Q37190801 |
| | Combination therapy in treatment of experimental pulmonary aspergillosis: in vitro and in vivo correlations of the concentration- and dose- dependent interactions between anidulafungin and voriconazole by Bliss independence drug interaction analysis | Q37204192 |
| | Bronchopulmonary disposition of intravenous voriconazole and anidulafungin given in combination to healthy adults | Q37450705 |
| | Lessons from animal studies for the treatment of invasive human infections due to uncommon fungi. | Q37865279 |
| | Effect of grapefruit juice on serum voriconazole concentrations in the mouse | Q39224290 |
| | Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis | Q39652561 |
| | In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp. | Q39652771 |
| | In vitro synergy of caspofungin and itraconazole against Aspergillus spp.: MIC versus minimal effective concentration end points | Q39743420 |
| | In vitro activity and in vivo efficacy of anidulafungin in murine infections by Aspergillus flavus | Q41857220 |
| | Efficacy of caspofungin and voriconazole combinations in experimental aspergillosis. | Q42286250 |
| | Efficacy of anidulafungin against Aspergillus niger in vitro and in vivo | Q42728132 |
| | In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp. | Q42949201 |
| | Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis | Q43154050 |
| | Susceptibility testing of anidulafungin and voriconazole alone and in combination against conidia and hyphae of Aspergillus spp. under hypoxic conditions | Q43183398 |
| | Anidulafungin: experimental therapy of fungal infections in animal models | Q44563761 |
| | Comparative in vivo activity of BAL4815, the active component of the prodrug BAL8557, in a neutropenic murine model of disseminated Aspergillus flavus | Q45034615 |
| | Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis | Q45063490 |
| | Combination antifungal therapy for invasive aspergillosis | Q45096994 |
| | Successful antifungal combination therapy with voriconazole and caspofungin | Q45256932 |
| | Safety and pharmacokinetics of coadministered voriconazole and anidulafungin | Q46807629 |
| | Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study | Q46943408 |
| | Combination antifungal therapy | Q76381447 |
| | Disseminated invasive aspergillosis with cerebral involvement successfully treated with caspofungin and voriconazole | Q80848547 |
| | [In vitro activity of the echinocandins. How should it be evaluated?] | Q81533852 |
| P433 | issue | 4 | |
| P921 | main subject | Aspergillus flavus | Q137096 |
| | voriconazole | Q412236 |
| P1104 | number of pages | 7 | |
| P304 | page(s) | 251-257 | |
| P577 | publication date | 2011-12-04 | |
| P1433 | published in | Mycopathologia | Q15763210 |
| P1476 | title | Combined therapy of voriconazole and anidulafungin in murine infections by Aspergillus flavus | |
| P478 | volume | 173 | |